Contact
searchSearch
HMP Global

Volume 22 - Issue 4 - April 2014

News

News
New Oral Therapy Approved to Treat Psoriatic Arthritis
04/14/2014
The oral medication apremilast (Otezla, Celgene Corporation) has been approved to treat adults with active psoriatic arthritis (PsA), the form of arthritis that affects some people with psoriasis. Typically, people develop psoriasis and are...
The oral medication apremilast (Otezla, Celgene Corporation) has been approved to treat adults with active psoriatic arthritis (PsA), the form of arthritis that affects some people with psoriasis. Typically, people develop psoriasis and are...
The oral medication apremilast...
04/14/2014
The Dermatologist

Column

Chief Medical Editor Message
Continuous Medical Treatment?
04/14/2014
One of the advantages touted of primary care is that it is continuous, that the doctor knows the patient and may have cared for the patient as a child and perhaps for the patients’ family. Even so, medical care tends to be discontinuous,...
One of the advantages touted of primary care is that it is continuous, that the doctor knows the patient and may have cared for the patient as a child and perhaps for the patients’ family. Even so, medical care tends to be discontinuous,...
One of the advantages touted of...
04/14/2014
The Dermatologist

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Popular Articles

News
Biologic Psoriasis Treatment Tied to Reactivation of Chronic HBV
05/23/2017
Patients diagnosed with psoriasis and chronic hepatitis B virus infection who are treated with biologic therapies are at increased risk of viral reactivation, according to recent research.
Patients diagnosed with psoriasis and chronic hepatitis B virus infection who are treated with biologic therapies are at increased risk of viral reactivation, according to recent research.
Patients diagnosed with...
05/23/2017
The Dermatologist
Actavis to Acquire Allergan
11/17/2014
Actavis plc and Allergan, Inc. entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock
Actavis plc and Allergan, Inc. entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock
Actavis plc and Allergan, Inc....
11/17/2014
The Dermatologist
Research in Review
Examining Rosacea & Comorbidities
04/18/2017
Rosacea is common but poorly understood condition of the facial skin. New scientific studies are looking at the potential link between rosacea and various comorbidities.
Rosacea is common but poorly understood condition of the facial skin. New scientific studies are looking at the potential link between rosacea and various comorbidities.
Rosacea is common but poorly...
04/18/2017
The Dermatologist
Special Report: Current & Emerging Therapies in Dermatology
07/25/2014
07/25/2014
The Dermatologist
Highlights From the AAD Annual Meeting
03/21/2017
Dermatologists from around the world gathered in Orlando, FL, for the 75th Annual Meeting of the American Academy of Dermatology to learn about the latest news and research in the field.
Dermatologists from around the world gathered in Orlando, FL, for the 75th Annual Meeting of the American Academy of Dermatology to learn about the latest news and research in the field.
Dermatologists from around the...
03/21/2017
The Dermatologist

Subscribe

The Dermatologist Newsletter

Latest Quizzes and Trivia

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

April 2014 Issue 4

View Issue Archive
Editorial Staff

VP, HMP Omnimedia: Kara Rosania
President, HMP Global: David DePinho
Senior Managing Editor: Coleen M.F. Stern
Associate Digital Editor: Jessica Garlewicz
Associate Editor: Riya Gandhi

Editorial Correspondence

Email: dermeditor@hmpglobal.com

Phone: (610) 560-0500
Fax: (866) 800-4236

Mailing Address
HMP Global
70E Swedesford Rd, Suite 100
Malvern, PA 19355

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use